Our Team

Akroprint’s founding team brings together over 21 years of combined experience in foreskin regeneration research and tissue engineering. With a proven track record of collaboration and innovation, our leadership is positioned to advance the world’s first scalable, 3D bioprinted solution for foreskin regeneration. 

Three of our founders co-authored the world’s first peer-reviewed scientific publication on foreskin regeneration, establishing them as thought leaders in this highly specialized field. Together, we bring scientific expertise and a deep understanding of the community of men impacted by circumcision and what is required to reverse it.

  • Tyler Drozd has over seven years of experience in foreskin-related tissue engineering, working as the Chief Operations Officer at Foregen, a nonprofit utilizing decellularized human tissues. In this role, he led strategic planning, donor relations, recruitment, and community engagement. A two-time Fulbright Scholar to Germany, Tyler represented the United States abroad while earning his MBA in Germany at FOM University of Applied Sciences for Economics and Management. He also holds a B.A. in World Languages from North Central College. Tyler combines scientific leadership with international business acumen to drive Akroprint’s mission forward.

Tyler Drozd

  • Eric Cunningham is a biomedical engineer and tissue engineering specialist with a rare depth of expertise in foreskin regeneration. Eric has a B.S. in Biomedical Engineering (specializing in Cell & Tissue Engineering), a Master’s of Chemical Engineering, and a Master’s of Engineering Management (specializing in Product Design and Development) from Illinois Institute of Technology. Eric has eight years of experience as a Chief Science Officer at Foregen, where he served as corresponding author of the world’s first peer-reviewed paper on the topic. 

    His background also includes:

    • Development of polymeric biomaterials for regenerative applications.

    • Creation of novel biomedical devices, including MRI imaging phantoms, neuromuscular rehabilitation tools, and brain biopsy training devices.

    • Contributions to the design of a biopharmaceutical manufacturing plant.

    Eric is one of the very few researchers worldwide with a comprehensive understanding of foreskin biology and function, making him a cornerstone of Akroprint’s technical vision.

Eric Cunningham

  • Matthew Serody brings six years of operational and strategic experience in foreskin regeneration research, previously serving as Senior Director at Foregen. He had a key role in revising the non-profit’s strategy, resulting in tripled revenues, and co-authored the first scientific paper on foreskin regeneration alongside Tyler and Eric.

    Matthew holds a B.S. in Viticulture & Enology from Cornell University with a Minor in Business for Life Sciences. He applies principles of bioprocessing and systems management to regenerative medicine, bridging bench-scale protocols and commercial production while maintaining administrative oversight.

Matthew Serody

  • Nick Heath graduated cum laude from Harvard College with an A.B. in Economics and a pre-med track in 2018. He spent five years in Strategic Finance at Roivant Sciences, a global biopharmaceutical company.

    In 2021, Nick played a key role on the four-person team that managed Roivant’s IPO through a SPAC merger—the second-largest biotech IPO at the time. His expertise in financial strategy, capital markets, and biotech growth pathways positions Akroprint for long-term success in commercialization.

Nicholas Heath

Our Advisors

  • Dr. Victor A. Ruthig is faculty at the University of Colorado Anschutz Medical Campus in the Section of Developmental Biology of the Department of Pediatrics. Dr. Ruthig’s research focuses on the genetics of sex determination; and genitourinary development and birth defects, especially in the context of the testis (male fertility) and penis (hypospadias). Victor’s expertise in this area includes his knowledge of state of the art microscopy methods, partnered with sequencing analysis, a significant aspect of Akroprint’s initial stage.

Victor A. Ruthig, Ph.D.

  • Elena Steiner is a Social Science Research Specialist at Arizona State University and holds a PhD in communication. She facilitates team research across humanities, social science, and computer science to learn how information is used in the digital space to guide attitudes, beliefs, and behavior. She has worked, lived in, or studied in 27 countries, and has presented across academic, non-profit, public, and private sector audiences on the influence of culture on communication, leadership, management, negotiation, and risk and security.

Elena Steiner, Ph.D.

Why Our Team Matters

Akroprint’s team combines scientific expertise, operational excellence, financial strategy, and community understanding. We are not only advancing the science of foreskin regeneration but also building the organizational and regulatory foundation to bring this solution to market.

Our unique combination of technical leadership and patient-centered mission makes Akroprint the only company in the world positioned to deliver a clinically viable, scalable, and personalized foreskin regeneration therapy.